Aignostics alternatives and competitors
The closest alternatives to Aignostics are Nucleai, Bioptimus, Biomy and Lunit SCOPE.
Aignostics builds foundation models for computational pathology and sells them, and applications built on them, to biopharmaceutical companies for target discovery, translational research, clinical trials and companion diagnostic development, and to pathology laboratories under research use terms.
10 alternatives to Aignostics
What each product does, with its price as the vendor publishes it.
-
N
Tissue intelligence company for drug development, applying computer vision and machine learning to H&E, immunohistochemistry, multiplex imaging and spatial transcriptomics and linking tissue features to clinical outcomes.
Price: No published price
-
B
Bioptimus is a Paris company that builds AI foundation models for pathology and biology. Drug companies, research groups and pathology software makers license them as a base for their own tools.
Price: No published price
-
B
Biomy makes DeepPathFinder, cloud software that uses AI to map immune and cancer cells on tissue slides for drug research.
Price: No published price
-
L
Lunit SCOPE is the pathology AI line of Lunit, the Seoul medical AI company. Drug companies, contract research organizations and digital pathology platforms use it to measure cancer biomarkers on tissue slides for research and trials.
Price: No published price
-
P
Proscia sells Concentriq, a digital pathology platform that clinical laboratories and life sciences organizations use to manage, view and analyze whole slide images.
Price: No published price
-
D
Deep Bio builds deep learning algorithms for cancer pathology, led by prostate.
Price: No pricing published; sold through third party platforms, unit of charge unstated
-
I
Imagene AI reads routine stained lung cancer slides and predicts which gene changes a tumor carries, without using more tissue for sequencing.
Price: No published price
-
D
Deciphex is a Dublin company founded in 2017 by Donal O'Shea, its chief executive, addressing the shortage of pathologists.
Price: No published price
-
I
Immunai occupies a different position from most of this category. It is not developing its own drugs.
Price: No published price
-
X
South San Francisco company founded in 2023 and launched publicly in April 2024 with more than $1 billion in committed funding, co led by ARCH Venture Partners and Foresite Labs.
Price: Not applicable
Aignostics alternatives, answered
What are the best alternatives to Aignostics?
The closest alternatives to Aignostics are Nucleai, Bioptimus, Biomy, Lunit SCOPE and Proscia. Bioptimus is a Paris company that builds AI foundation models for pathology and biology. Biomy makes DeepPathFinder, cloud software that uses AI to map immune and cancer cells on tissue slides for drug research. Lunit SCOPE is the pathology AI line of Lunit, the Seoul medical AI company.
Who are Aignostics's competitors?
Aignostics's competitors in the Digital Pathology AI category include Nucleai, Bioptimus, Biomy, Lunit SCOPE, Proscia and Deep Bio.